Literature DB >> 10589545

Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.

X P Zhou1, M Sanson, K Hoang-Xuan, E Robin, L Taillandier, J He, K Mokhtari, P Cornu, J Y Delattre, G Thomas, R Hamelin.   

Abstract

Constitutional DNA from 44 selected patients suspected of being genetically predisposed to develop astrocytic tumors was analyzed for germline mutations of the p53, p16, and PTEN genes. Six constitutional missense mutations of the p53 gene were identified (13.6%), but no mutations of the p16 and PTEN genes were found, suggesting that (1) germline p53 mutations contribute to a small portion of astrocytic tumors, (2) inherited mutations of the p16 and PTEN gene do not predispose to the development of gliomas, and (3) other genes are involved in glioma predisposition.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10589545     DOI: 10.1002/1531-8249(199912)46:6<913::aid-ana15>3.0.co;2-x

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  6 in total

Review 1.  Molecular epidemiology of primary brain tumors.

Authors:  Jun Gu; Yanhong Liu; Athanassios P Kyritsis; Melissa L Bondy
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

Review 2.  Genetic advances in glioma: susceptibility genes and networks.

Authors:  Yanhong Liu; Sanjay Shete; Fay Hosking; Lindsay Robertson; Richard Houlston; Melissa Bondy
Journal:  Curr Opin Genet Dev       Date:  2010-03-06       Impact factor: 5.578

Review 3.  Inherited predisposition to glioma.

Authors:  Athanassios P Kyritsis; Melissa L Bondy; Jasti S Rao; Chrissa Sioka
Journal:  Neuro Oncol       Date:  2009-11-23       Impact factor: 12.300

Review 4.  Glioblastoma genetics: in rapid flux.

Authors:  Benjamin W Purow; David Schiff
Journal:  Discov Med       Date:  2010-02       Impact factor: 2.970

5.  A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene.

Authors:  Naohiro Izawa; Seiichi Matsumoto; Jun Manabe; Taisuke Tanizawa; Manabu Hoshi; Toshio Shigemitsu; Rikuo Machinami; Hiroaki Kanda; Kengo Takeuchi; Yoshio Miki; Masami Arai; Shuya Shirahama; Noriyoshi Kawaguchi
Journal:  Int J Clin Oncol       Date:  2008-02-29       Impact factor: 3.402

Review 6.  Advances in the genetics of glioblastoma: are we reaching critical mass?

Authors:  Benjamin Purow; David Schiff
Journal:  Nat Rev Neurol       Date:  2009-07-14       Impact factor: 44.711

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.